In renal cell carcinoma, the JNK pathway—particularly JNK1—has a dual role, both promoting and suppressing tumor development, affecting tumor growth, the microenvironment, and treatment response [50]. Here, MAPK8 is linked to hereditary clear cell renal cell carcinoma.